Is there a vaccine for Neisseria meningitidis type B?
The FDA is announcing the approval of Trumenba, the first vaccine approved in the United States to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age. Trumenba is manufactured by Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.
What type of vaccine is meningitis B?
The meningococcal B vaccine (MenB) protects against a fifth type of meningococcal bacterium (called type B). It is fairly new and not yet recommended as a routine vaccination for healthy people. But some kids and teens who are at increased risk for meningococcal disease should get it starting from age 10.
What is the vaccine for Neisseria meningitidis?
Vaccines can help prevent meningococcal disease, which is any type of illness caused by Neisseria meningitidis bacteria. There are 2 types of meningococcal vaccines available in the United States: Meningococcal conjugate or MenACWY vaccines (Menactra®, Menveo®, and MenQuadfi®)
Can you vaccinate against meningitis B?
The meningitis B vaccine is a vaccine that offers protection against meningococcal group B bacteria, which are a common cause of meningitis in young children in the UK. The vaccine is recommended for babies aged 8 weeks, followed by a second dose at 16 weeks and a booster at 1 year.
Is meningococcal B vaccine required for college?
CDC recommends a meningococcal conjugate (MenACWY) vaccine for first-year college students living in residence halls. If they received it before their 16th birthday, they need a booster shot for maximum protection before going to college.
Who is the meningococcal B vaccine recommended for?
Meningococcal B vaccines are recommended for people 10 years or older who are at increased risk for serogroup B meningococcal disease, including: People at risk because of a serogroup B meningococcal disease outbreak.
What is meningitis B?
Meningococcal group B disease (also known as meningitis B) is an uncommon but serious disease that is caused by a bacterial infection of the lining of the brain and spinal cord. It can also cause a severe infection of the blood called meningococcal septicemia.
Who needs the meningitis B vaccine?
Meningococcal B vaccines are recommended for people 10 years or older who are at increased risk for serogroup B meningococcal disease, including: People at risk because of a serogroup B meningococcal disease outbreak. Anyone whose spleen is damaged or has been removed, including people with sickle cell disease.
Does MCV4 cover meningitis B?
Teens and young adults may receive the meningococcal conjugate vaccine (MCV4), covering the four most common bacterial serotypes — A, C W, and Y — or the serogroup B meningococcal vaccine (MenB). These are both used to prevent bacterial meningitis.
When did meningitis B vaccine start?
On 14 June 2012, the FDA approved a combination vaccine against two types of meningococcal disease and Hib disease for infants and children 6 weeks to 18 months old. The vaccine, Menhibrix, prevents disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b.
What is the difference between meningitis and meningitis B?
Meningitis B is one type of meningococcal disease (frequently referred to as meningitis) caused by the bacteria Neisseria meningitidis. Meningitis can attack the brain and spinal cord and cause swelling in those areas as well as a serious infection of the bloodstream, called septicemia.